Kota Ouchi

6PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyCancer geneticsMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 23, 2026
Inverse Relation Between Responses to Pembrolizumab Plus Chemotherapy and Subsequent Cetuximab Plus Paclitaxel in Head and Neck Cancer: Role of the Janus Kinase-Signal Transducer and Activator of Transcription Signaling Pathway.

|Aug 14, 2025
Plasma Lysophosphatidylcholine Levels Correlate with Prognosis and Immunotherapy Response in Squamous Cell Carcinoma.

Tomoyuki Iwasaki, Hidekazu Shirota, Eiji Hishinuma

|Sep 26, 2024
Specific cancer types and prognosis in patients with variations in the KEAP1-NRF2 system: A retrospective cohort study.

Tomoyuki Iwasaki, Hidekazu Shirota, Keiju Sasaki

|Jul 27, 2024
Efficacy of anti-epidermal growth factor antibody rechallenge in RAS/BRAF wild-type metastatic colorectal cancer: a multi-institutional observational study.

Koshiro Fukuda, Hiroki Osumi, Yuri Yoshinami

|Apr 11, 2022
Altered gene expression due to aberrant DNA methylation correlates with responsiveness to anti-EGFR antibody treatment.

Yasufumi Otsuki, Kota Ouchi, Shin Takahashi

|Dec 28, 2021
A modified MethyLight assay predicts the clinical outcomes of anti-epidermal growth factor receptor treatment in metastatic colorectal cancer.

Kota Ouchi, Shin Takahashi, Akira Okita

Pageof 1

Frequent Collaborators

5 joint publications

Chikashi Ishioka

2 joint publications

Shin Takahashi

2 joint publications

Ken Saijo

2 joint publications

Hidekazu Shirota